Charles's Story
When Charles Grashow received concerning test results in 2020 and 2021 showing developing coronary artery disease (CAD), he decided to take action. Over the next two years, Charles implemented an intensive lifestyle, diet, and supplementation regimen aimed at regressing the plaques in his heart's arteries - and it worked. As evidenced by his latest test results, Charles successfully reversed the trajectory of his CAD.
The Start of Charles's Journey
In June 2020, a heart CT scan delivered Charles's first warning, detecting minimal coronary calcification and enlarged pulmonary arteries. While not yet serious, these were early signs of potential issues. By December 2021, a follow-up scan showed Charles's coronary artery calcium score had worsened and now indicated definite, albeit still mild, CAD.
At this point, Charles faced a choice - proceed as usual down the path of advancing atherosclerosis or work diligently to stop and turn back the clock. Motivated by his belief in science and self experimentation, Charles chose the latter.
The Key Components of Charles's Protocol
Charles put together a multi-prong, evidence-based plan attacking CAD from all angles:
Diet - Charles always had a healthy diet.
Exercise & Weight - Though not overweight, Charles always did his weekly cardiovascular exercise and strength training to improve circulatory health.
Supplements & Off Label Drugs - After extensive research Charles introduced various supplements, mostly targeted at lowering LDL particles (“bad” cholesterol), reducing inflammation and oxidative damage, and boosting nitric oxide production for improved vascular function. He followed a general approach to improve his longevity through off label drugs and supplements. He started taking high dose nattokinase (8k FU). Targeted an LDL of 30 mg/dL, and very low inflammation (HS-CRP of 0.5).
The proof is in the plaque - or lack thereof. A June 2023 CT heart scan showed stunning results...
The Payoff: CAD Reversal Documented
An eagerly awaited CT heart scan in June 2023, two and a half years after starting his intensified protocol, brought Charles definitive proof his approach worked.
Some key takeaways:
- Charles's coronary artery calcium score, the most telling indicator of atherosclerotic plaque, significantly improved from initial 102 to 32, dropping by over 2/3rds.
- The radiologist formally classified Charles's status as CAD RADS 1, meaning only minimal evidence of CAD presently with just eccentric calcified segments causing insignificant vessel narrowing.
- Structurally, Charles's heart and arteries all checked out as normal and within proper limits.
Simply put, Charles achieved regression of his coronary artery disease - the improved state reflected in his scans confirms this remarkable outcome.
While anecdotal and n=1, Charles’s restoration of cardiovascular wellness illuminates the real potential for nutrition, exercise, select supplements and drugs to favorably influence aging and turn around atherosclerosis.
Charles's Labs (8/2/23)
Lipids:
- TC - 111
- TG - 45
- HDL - 65
- VLDL - 11
- LDL (Calculated) - 35
Liver:
- AST - 26
- ALT - 25
Others:
- Glucose - 98
- Insulin - 3.2
- A1C - 5.6
- Uric Acid - 4.3
- Ferritin - 62
- hsCRP - 0.53
- Vitamin D, 25-Hydroxy - 65.4 Ref Range 30 - 100
Since I'm taking high dose Nattokinase I also had my clotting time measured
INR - 1.1 Ref Range 0.9 - 1.2 for non anti-coagulated patients
Prothrombin Time - 11.2 Ref Range 9.1 - 12.0
aPTT - 29 Ref Range 24-33
Charles's Longevity Stack (03/2023)
For cardiovascular/plaque reduction
- 20mg Rosuvastatin
- 10mg Ezetimibe
- 40mg Telmisartan
- 600mg Bergamet Citrus Bergamot
- 1/2 teaspoon Alpha Cyclodextrin
- 1/2 teaspoon (2-Hydroxypropyl) -beta-cyclodextrin
- 200mg 2-Hydroxybenzylamine (2-HOBA)
- 300mg 2x/day Pantesin Pantethine
- 50mg 2x/day Ubiquinol CoQ-10
- 600mg 2x/day Chondrotin Sulfate
- 300mg Nutricost Pine Bark Extract
- 120mg Nootropics Depot Gotu Kola
- 8000FU Nattokinase
- 80000SPU Enteric Coated Serrapaptase
Lifespan/Healthspan Extension
- 12mg Sirolimus Every 14 days (Vegetarian, Dye Free, Acid Resistant Capsules)
- 25mg Dasatinab & 250mg Quercitin for 3 consecutive days - repeat every 2 weeks for a total of 4 cycles. Repeat in 6 months
- 1500mg Fisetin for 3 consective days monthly
- 12mg Astaxanthin
- 2 capsules Thalacy Fermented Wheat Germ Extract (1300mg standardized to 1% Spermidine)
- 12.5 mg L-Ergothioneine
- 500mg 2x/day Folius Berberine
- 2.5mg Deprenyl 3x/week
General Health
- 500mg NMN & 500mg TMG
- 500mg L-Carnosine
- 500mg Celadrin
- 160mg Benfotiamine
- 120mg Pure Encapsulations Boswellia AKBA
- 1 Swanson Synergistic Eye Health
- 1 Swanson Provinal Purified Omega-7
- 500mg Reduced Glutathione
- 1 Jarrow Formulas B-Right. I have the MTHFR polymorphism
- 1 Cosamin ASU
- 1 Microbiome Plus+ Lactobacillus Reuteri 30242
- 120mg 2x/day Magnesium Taurate
- 12mg 2x/day Magnesium Glycinate
- Magnesium L-Threonate
- 1 capsule Life Extension Optimized Resveratrol Elite
- 1 Capsule Life Extension Pro-Resolving Mediators
- 1 Capsule Life Extension MacuGurad with Saffron & Asataxantin (6mg)
- 1 Capsule Life Extension Optimized Fucoidan with Maritech 926
- 600mg NAC
- 500mg Shark Liver Oil standardized to 20% Alkylglycerols
- Life Extension Memory Protect
- 200mg Hyaluronic Acid
- 5000IU Vitamin D3
- 250mg Shilajit Extract
- 400mg (Palmitoylethanolamide) PEA
- 500mg Taurine
- 500mg Apigenin
- 250mg Relora
- Life Extension Super R-Lipoic Acid
- Swanson White Willow Bark Standardized to 25% Saloon
##
Coronary Scan Results
- June 11, 2020 - CT Heart Structure & Morphology with Contrast
- Calcium Score: 100.69, placing you in the 51st percentile for your age and gender.
- Findings:
- Left Anterior Descending (LAD) and Right Coronary Artery (RCA): Minimal coronary calcification with no significant soft plaque or hemodynamically significant stenosis.
- Other Observations: Pulmonary arteries are enlarged, which could suggest pulmonary hypertension.
- December 6, 2021 - CTA Heart Coronary Arteries & Bypass Graft with Contrast
- Calcium Score: Increased significantly to 102.9.
- Findings:
- LAD: Mild stenosis caused by calcified plaques.
- RCA: Mild stenosis from calcified plaque.
- Overall: Indicative of CAD RADS 2, suggesting mild but definite evidence of coronary artery disease.
- June 22, 2023 - CTA Heart Coronary Arteries & Bypass Graft with Contrast
- Calcium Score: Decreased to 32.01, in the 32nd percentile for your age and gender.
- Findings:
- LAD: Prominent eccentric calcification causing mild luminal narrowing.
- RCA: Eccentric calcified plaque producing minimal luminal narrowing.
- Overall: CAD RADS 1, indicating minimal but recognizable coronary artery disease.
Comparative Analysis
- Calcium Score Trend: There's an interesting trend in your calcium scores. It was high in 2020, slightly increased in 2021, and then significantly decreased in 2023. This suggests an excellent improvement in your heart's condition.
- Plaque Development: In 2020 and 2021, there were concerns about mild stenosis in LAD and RCA. However, by 2023, the situation seems to have improved, as indicated by the lower calcium score and CAD RADS 1 classification.
- Overall Heart Health: Your heart's structure and major vessels have generally been reported as normal or within normal limits across all scans.


